biotechnology

How medical technology will transform human life - Siddhartha Mukherjee

GZERO World Clips

How medical technology will transform human life - Siddhartha Mukherjee

On GZERO World, Ian Bremmer and Siddhartha Mukherjee explore the many ways medical technology will transform our lives and help humans surpass physical and mental limitations.

Siddhartha Mukherjee: CRISPR, AI, and cloning could transform the human race

GZERO World Clips

Siddhartha Mukherjee: CRISPR, AI, and cloning could transform the human race

Technologies like CRISPR gene editing, synthetic biology, bionics integrated with AI, and cloning will create "new humans," says Dr. Siddhartha Mukherjee on the latest edition of GZERO World with Ian Bremmer.

From CRISPR to cloning: The science of new humans

GZERO World with Ian Bremmer

From CRISPR to cloning: The science of new humans

On GZERO World, Ian Bremmer sits down with physician and biologist Siddhartha Mukherjee to explore the recent advances, benefits, and risks of human enhancement with technology.

A graphical representation of the human head | GZERO World with Ian Bremmer the podcast

GZERO World with Ian Bremmer Podcast

Podcast: Tracking the rapid rise of human-enhancing biotech with Siddhartha Mukherjee

Listen: Medical and biotechnologies like gene editing with CRISPR, synthetic organs, cloning, and AI-powered prosthetics that are helping to eradicate disease, and improve the human condition. But there’s also potential for misuse and ethical implications. Ian Bremmer delves into that tension on the GZERO World Podcast with physician and biologist Siddhartha Mukherjee.

Ian Explains: Will biotech breakthroughs lead to super humans?

Ian Explains: Will biotech breakthroughs lead to super humans?

Medical technology could lead to a new breed of super humans. On Ian Explains, Ian Bremmer looks at the evolution of human enhancement, tracing its roots from ancient history to recent ground-breaking tools like CRISPR gene editing, AI-powered prosthetics, and brain implants.

Operation Warp Speed: Does credit for Moderna’s COVID vaccine go to the US taxpayer?

GZERO World Clips

Operation Warp Speed: Does credit for Moderna’s COVID vaccine go to the US taxpayer?

Without the help of the US government initiative "Operation Warp Speed," Moderna co-founder Noubar Afeyan says that it would have been impossible for the company to develop and deliver its vaccine so quickly. The fact, he says, that the American people may be days away from receiving its first doses is, in large part, thanks to their taxpayer dollars. Does President Trump, himself, deserve credit? "Without caveat," Afeyan says. He spoke with Ian Bremmer on GZERO World.

How development of the COVID-19 vaccine shattered records

GZERO World Clips

How development of the COVID-19 vaccine shattered records

They said it couldn't be done: a vaccine developed in record time. In 1967, Merck had a license for a mumps vaccine, less than five years for work that normally takes decades. But that record is now being shattered as the COVID-19 vaccine reaches the market in less than a year. It's an unprecedented scientific development in a whirlwind year of crisis.

Podcast: COVID Vaccine in Record Time - What Now? Moderna Co-Founder Noubar Afeyan

GZERO World with Ian Bremmer Podcast

Podcast: COVID Vaccine in Record Time - What Now? Moderna Co-Founder Noubar Afeyan

Listen: The pandemic's US death toll shows no signs of abating and the holiday season's spike will likely dwarf any surge that came before it. But in the midst of this dark winter there are glimmers of hope, as the first of the COVID-19 vaccines have nearly arrived (or, depending on when you read this, already have). On the GZERO World Podcast, Ian Bremmer interviews Noubar Afeyan, the co-founder of a leading vaccine developer Moderna. They'll discuss distribution plans, the revolutionary science behind Moderna's vaccine, and how a company younger than Twitter became a frontrunner in the race to end the pandemic.

How the Moderna vaccine works, why it’s effective, and how it’ll be distributed

GZERO World Clips

How the Moderna vaccine works, why it’s effective, and how it’ll be distributed

"What we're trying to do is to educate the immune system to see the protein before it's seen the virus." In a race for a COVID vaccine, Moderna, a 10-year old company with no products previously on the market, developed a vaccine in 10 months, by using revolutionary new mRNA technology. Now the focus shifts to how to distribute and safely administer this vaccine. Moderna co-founder and chairman Noubar Afeyan explains.

His conversation with Ian Bremmer was part of the latest episode of GZERO World, which began airing nationally in the US on public television Friday, December 11th. Check local listings.